FDA Drug Application (021004) for EPIVIR-HBV by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number021004
Product Number001
FormSOLUTION;ORAL
Dosage5MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEPIVIR-HBV
Active IngredientLAMIVUDINE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39


Back to FDA Applications sponsored by GLAXOSMITHKLINE